Operating income decreased 31.5%
Operating income changed -31.5% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed -31.5% from the comparable as-filed period.
Operating margin changed +852 basis points from the comparable as-filed period.
Revenue changed +38.6% from the comparable as-filed period.
Gross margin changed +2681 basis points from the comparable as-filed period.
Research & development changed +84.9% from the comparable as-filed period.
Cash & equivalents changed -90.7% from the comparable as-filed period.
Current liabilities changed -83.7% from the comparable as-filed period.
Selling, general & administrative changed +46.0% from the comparable as-filed period.
Shares outstanding changed -96.8% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.